About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in Texas | 723 Studies

Clinical Trials Colorectal CancerTexas

Colorectal Cancer Clinical Trials in Texas

Find 723 clinical trials for colorectal cancer near Texas. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 161-180 of 723 trials

UnknownA Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid TumorsA first-in-human (FIH) study using SBT6050 and SBT6050 in combination with PD-1 inhibitors in HER2 expressing or amplified advanced malignanciesNCT04460456·Boston, Massachusetts and 11 others RecruitingMinimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C StudyThis study investigates if circulating tumor DNA (ctDNA) and other tumor-related molecules/chemicals released in the blood can help doctors predict if colorectal cancer may come…NCT04739072·Gilbert, Arizona and 9 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedStudy of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRCThe purpose of this study is to evaluate the preliminary efficacy and safety of NIS793 and other novel investigational combinations with standard of care (SOC) anti-cancer therapy…NCT04952753·Los Angeles, California and 54 others

CompletedPEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) TumorsThe primary objective of this study is to estimate the treatment effect on progression-free survival (PFS) of panitumumab relative to bevacizumab in combination with mFOLFOX6…NCT00819780·Birmingham, Alabama and 94 others

Active not recruitingStudy to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid TumorsThe study will determine the recommended Phase 2 dose (RP2D) of livmoniplimab (ABBV-151) administered as monotherapy and in combination with budigalimab (ABBV-181) as well as to…NCT03821935·Springdale, Arkansas and 63 others

RecruitingStudy of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC FusionsThis is a Phase 1/2, multi-center, open-label basket study designed to evaluate the safety and anti-tumor activity of IDE196 in patients with solid tumors harboring GNAQ or GNA11…NCT03947385·Los Angeles, California and 14 others

TerminatedA Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor ReceptorThis is an open-label, Phase I, dose escalation study to determine the recommended Phase 2 dose, maximum tolerated dose, and evaluate the safety and pharmacokinetic profile of…NCT02365662·Boston, Massachusetts and 4 others

WithdrawnA Pilot Randomized Trial of a Comprehensive Transitional Care Program for Colorectal Cancer PatientsThe primary hypothesis is that a comprehensive transitional care program based on the premise of a patient-centered medical home versus routine care reduces emergency room visits…NCT02202096·Houston, Texas

RecruitingA Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C MutationsTo learn if the drug combination of adagrasib, cetuximab, and cemiplimab can help to control metastatic CRC with KRAS G12C mutations.NCT06412198·Boston, Massachusetts and 1 other

TerminatedA Study of NM21-1480 in Adult Patients With Advanced Solid TumorsThis is a first-in-human, open-label, multi-center, Phase 1/2, dose-escalation study with expansion cohorts to evaluate NM21-1480 for safety and immunogenicity, to determine the…NCT04442126·Fort Collins, Colorado and 25 others

TerminatedCelecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal CancerRATIONALE: Radiation therapy uses high energy x-rays to kill tumor cells.NCT00305643·Santa Rosa, California and 13 others

CompletedStudy of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic CancerThis study evaluated the safety and efficacy of VE800 in combination with nivolumab in patients with selected types of advanced or metastatic cancerNCT04208958·Scottsdale, Arizona and 17 others

CompletedArginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid TumorsThis study is an open-label Phase 1/Phase 2 evaluation of INCB001158 as a single agent and in combination with immune checkpoint therapy in patients with advanced/metastatic solid…NCT02903914·Mobile, Alabama and 19 others

CompletedCare Coordination for Complex Cancer Survivors in an Integrated Safety Net SystemNearly 70% of people living with cancer are "complex patients" with multiple chronic conditions who must deal not only with effects of their cancer but also continuing diseases…NCT02943265·Dallas, Texas

WithdrawnCBX-12 for the Treatment of Metastatic Chemotherapy-Refractory Microsatellite Stable Colorectal CancerThis phase II trial studies how well CBX-12 works in treating patients with microsatellite stable colorectal cancer that has spread to other parts of the body (metastatic) and is…NCT06730100·Irvine, California and 14 others

CompletedA Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid TumorsThe primary objectives of this study are to: * Evaluate the safety and tolerability of AMG 355 as monotherapy and in combination with pembrolizumab in participants with advanced…NCT06131398·Duarte, California and 24 others

Active not recruitingA Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal CancerThe purpose of this study is to learn about the effects of three study medicines (encorafenib, cetuximab, and pembrolizumab) given together for the treatment of colorectal cancer…NCT05217446·Phoenix, Arizona and 58 others

RecruitingA First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid TumorsA Phase 1, First in Human, Open-Label Multicenter Study to Evaluate ALX2004, an Antibody Drug Conjugate Targeting EGFR in Participants with Advanced or Metastatic Select Solid…NCT07085091·Tampa, Florida and 7 others

RecruitingA Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)This open-label, exploratory study is designed to evaluate the safety and efficacy of targeted therapies or immunotherapy as single agents or combinations, in participants with…NCT04929223·Birmingham, Alabama and 83 others

TerminatedStudy of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological MalignanciesThis is a phase I/II, non randomized, open-label, dose escalation study to investigate the safety, tolerability and preliminary efficacy of CB-103.NCT03422679·Santa Monica, California and 16 others

PreviousPage 9 of 37Next

Other Conditions in Texas

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma